Exam #2 Flashcards
Treatment for Bipolar disorder
Normal
Anti seizure drugs
Antipsychotics
Normal: lithium Anti seizure drugs: - valproic acid - carbazepime - Lamatrigine Antipsychotics: - Quetiapine
Lithium MOA
- activates GABA release
- inhibits glutamate and dopamine
- inhibits phosphoinositol cascade (IP3 and DAG pathway)
- Inhibition of glycogen synthase kinase-3 (GSK-3) leading to neuroprotection
Lithium therapeutic range
0.6-1.5 mEq/L
Lithium Pharmokinetics
Competes w Na+ for tubular reabsorption in the kidneys (Lithium can be in by Na+ loss often seen in diuretic use)
-diuretics can inc lithium concentration
Lithium Adverse Effects
Hypothryroidism (weight gain, dry skin, hair loss, and constipation)
Tremors
Ataxia (ESP WHEN PAIRED W ATYPICAL PSYCHOTICS)
Nephrogenic diabetes insipidus (dec response to ADH leading to polyuria)
Nausea, vomiting, diarrhea
PREGNANCY = Ebstein anomaly
Carbamazepine CYP
inducer
Monoamine Hypothesis
Depression resulting from pathological dec in serotonin, NE, and/or dopamine neurotransmission
Neurotropic Hypothesis
Loss of neurotrophic support leading to depression (Brain derived neurotrophic factor)
Hypothalamic-Pituitary-Adrenal Axis Dysregulation
Elevated levels of cortisol and CRH
Thyroid Dysregulation
Depression associated w hypothyroidism or hyperthyroidism
SSRIs names
Fluoxetine Paroxetine Sertraline Citalopram Escitalopram Vilazadone
SNRIs names
Duloxetine
Venlafaxine
Milnacipran
Levomilnacipran
initial inhibition of SERT induces
activation of 5-HT1A and 5-HT1D autoreceptors
TCS names
Imipramine
Amitriptyline
TCA nonselective effects
Antimuscarinic
Antihistaminic
Alpha-blockade
5-HT2 Antagonists
Trazodone
Nefazodone
5-HT2 Antagonists Nonselective effects
Antimuscarinic, antihistamine, alpha-blockade
MOA-A and MOA-B irreversible inhibitors
Phenelzine
Tranylcypromine
MOA-B irreversible inhibitor only
Selegiline
bupropion MOA
inhibits the norepinephrine transporter (NET) and the dopamine transporter (DAT)
Mirtazapine moa
alpha-2 inhibition increases presynaptic release of serotonin and norepinephrine
Trazodone moa
serotonin modulator (antagonizes 5-HT receptors and inhibits 5-HT reuptake)
increased risk of suicide between children, adolescents and young adults. SSRI SNRI TCA MOA inhibitor Atypical
SSRIs: -Escitalopram -Fluoxetine SNRIs: -Duloxetine TCAs: -Imipramine MOA inhibitor: -Phenelzine Atypical: -Bupropion
Schizophrenia pathology
- Inc dopaminergic activity (D2 receptor)
- Inc serotonergic activity (5-HT2A and 5-HT2C)
- Diminished GABA activity leading to hyperstimulation